David Grahame. Grahame-smith

David Grahame. Grahame-smith's AcademicInfluence.com Rankings

Biology

#7452

World Rank

#10382

Historical Rank

Neuroscience

#973

World Rank

#1014

Historical Rank

biology Degrees

Download Badge

Biology

David Grahame. Grahame-smith's Degrees

Masters Biology Stanford University

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is David Grahame. Grahame-smith Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David Grahame. Grahame-smith's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN (1971) (656)
5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis (1989) (346)
Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex. (1967) (313)
Oxford Textbook of clinical pharmacology and drug therapy (1985) (214)
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. (1996) (198)
Evidence based medicine: Socratic dissent (1995) (194)
Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine (1976) (188)
Tryptophan hydroxylation in brain. (1964) (188)
Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone (1983) (155)
ELECTROCONVULSIVE SHOCK INCREASES THE BEHAVIOURAL RESPONSES OF RATS TO BRAIN 5‐HYDROXYTRYPTAMINE ACCUMULATION AND CENTRAL NERVOUS SYSTEM STIMULANT DRUGS (1976) (148)
MECHANISM OF THE ANTIDEPRESSANT ACTION OF ELECTROCONVULSIVE THERAPY (1978) (146)
Pharmacological characterization of 8‐OH‐DPAT‐induced inhibition of rat hippocampal 5‐HT release in vivo as measured by microdialysis (1989) (146)
Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain (1999) (145)
Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. (1978) (140)
(−)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system (1976) (123)
Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour (1976) (118)
THE ROLE OF BRAIN 5‐HYDROXYTRYPTAMINE IN THE HYPERACTIVITY PRODUCED IN RATS BY LITHIUM AND MONOAMINE OXIDASE INHIBITION (1974) (115)
The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. (1974) (115)
Behavioural evidence for a functional interaction between central 5‐HT2 and 5‐HT1A receptors (1990) (108)
Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. (1998) (107)
Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. (1990) (106)
The biosynthesis of 5-hydroxytryptamine in brain. (1967) (103)
The effects of iron deficiency on brain biogenic monoamine biochemistry and function in rats (1980) (102)
Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes. (1984) (93)
TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats (1974) (89)
Human platelet monoamine oxidase activity in iron-deficiency anaemia. (1975) (88)
5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. (1993) (88)
Measurement of Digoxin in Plasma and its use in Diagnosis of Digoxin Intoxication (1969) (87)
Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage. (1976) (84)
Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: Sensitivity to tetrodotoxin, calcium and calcium antagonists (1990) (83)
Evidence for presynaptic 5-hydroxytryptamine3 recognition sites on vagal afferent terminals in the brainstem of the ferret (1990) (80)
Effect of acute administration of L-tryptophan on the release of 5-HT in rat hippocampus in relation to serotoninergic neuronal activity: an in vivo microdialysis study. (1992) (80)
Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694) (1991) (79)
EFFECT OF ORAL CONTRACEPTIVES ON PLATELET NORADRENALINE AND 5-HYDROXYTRYPTAMINE RECEPTORS AND AGGREGATION (1979) (78)
Serotonin2/1 C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres (1993) (78)
Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice. (1971) (70)
Nausea and Vomiting: Mechanisms and Treatment (1986) (65)
A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma. (1977) (64)
Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia. (1979) (64)
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. (1975) (64)
Localization of 5-HT3 receptor binding sites in human dorsal vagal complex. (1989) (63)
CHANGES IN PLATELET α2-ADRENOCEPTOR BINDING POST PARTUM: POSSIBLE RELATION TO MATERNITY BLUES (1983) (63)
Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites (2000) (62)
HPLC-EC analysis of catechols and indoles in rat brain dialysates. (1987) (61)
The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function (1975) (61)
Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes. (1975) (57)
Tranylcypromine (‘Parnate’) overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma (1979) (56)
ELECTROCONVULSIVE THERAPY AND THE BRAIN: EVIDENCE FOR INCREASED DOPAMINE-MEDIATED RESPONSES (1982) (55)
Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock. (1979) (55)
The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects. (1972) (54)
Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission. (1985) (51)
Abnormal regulation of adenosine 3',5'-monophosphate and corticosterone formation in an adrenocortical carcinoma. (1969) (51)
BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors (1993) (51)
Human platelet 5HT receptors: characterisation and functional association. (1980) (50)
WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones. (1994) (50)
Altered in vitro adaptive responses of lymphocyte Na+,K(+)-ATPase in patients with manic depressive psychosis. (1991) (49)
Altered distribution of digoxin in renal failure--a cause of digoxin toxicity? (1976) (49)
Abnormal function of potassium channels in platelets of patients with Alzheimer's disease (1998) (47)
Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response. (1977) (46)
Variation in Sensitivity of DNA Synthesis to Ara‐C in Acute Myeloid Leukaemia (1980) (44)
Oestrogen and progesterone change the binding characteristics of alpha-adrenergic and serotonin receptors on rabbit platelets. (1980) (44)
Studies on the mechanisms by which clenbuterol, a β-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat (1983) (43)
Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain (1997) (41)
Changes in Plasma Catecholamines and Dopamine Beta-Hydroxylase after Corrective Surgery for Coarctation of the Aorta (1978) (40)
Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity. (1978) (40)
Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation. (1979) (40)
Alcohol-stimulated calcitonin release in medullary carcinoma of the thyroid. (1973) (39)
5-Hydroxytryptamine and Other Indoles in the Central Nervous System (1975) (37)
Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro (1991) (36)
5-HT2A Receptor Activation Leads to Increased BDNF mRNA expression in C6 glioma cells (2007) (36)
Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment. (1989) (36)
The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: Evidence for the non-involvement of dopamine sensitive adenylate cyclase (1976) (35)
5-HT1A and 5-HT2 receptors differentially regulate the excitability of 5-HT-containing neurones of the guinea pig dorsal raphe nucleus in vitro (2001) (35)
The relationship between plasma catecholamines and severity of injury in man. (1984) (35)
Unchanged Rate of Brain Serotonin Synthesis during Chronic Morphine Treatment and Failure of Parachlorophenylalanine to attenuate Withdrawal Syndrome in Mice (1970) (34)
THE BINDING CHARACTERISTICS OF [3H]‐DIHYDROERGOCRYPTINE ON INTACT HUMAN PLATELETS (1982) (34)
Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine (1977) (34)
Bioavailability of digoxin. (1972) (33)
Some properties of human platelet monoamine oxidase in iron-deficiency anaemia. (1976) (33)
5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration. (1995) (32)
Influence of thyroid hormone on 5-HT1A and 5-HT2A receptor-mediated regulation of hippocampal BDNF mRNA expression (2001) (32)
ONTOGENESIS OF ENZYME SYSTEMS DEAMINATING DIFFERENT MONOAMINES (1976) (31)
Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus (2000) (31)
GABAB receptor activation inhibits 5-hydroxytryptamine-stimulated inositol phospholipid turnover in mouse cerebral cortex. (1988) (30)
Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leucocytes. (1985) (30)
The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy. (1979) (30)
Serotonin function in affective disorders (1989) (28)
The effect of metergoline on endocrine responses to L-tryptophan (1987) (27)
Lithium enhances 5-HT2A receptor-mediated c-fos expression in rat cerebral cortex. (1993) (27)
Evidence for increased in vivo Na(+)-H+ antiporter activity and an altered skeletal muscle contractile response in the spontaneously hypertensive rat. (1990) (27)
Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat c6 glioma cells (1995) (26)
British Journal of Clinical Pharmacology (2013) (26)
A short period of hypoxia produces a rapid and transient rise in [K+]e in rat hippocampus in vivo which is inhibited by certain K+-channel blocking agents (1995) (25)
TRYPTOPHAN HYDROXYLATION IN CARCINOID TUMOURS. (1964) (25)
Action of adenosine receptor antagonists on hypoxia‐induced effects in the rat hippocampus in vitro (1995) (25)
DOES THE TOTAL TURNOVER OF BRAIN 5-HT REFLECT THE FUNCTIONAL ACTIVITY OF 5-HT IN BRAIN? (1973) (24)
Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution. (1977) (24)
Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels (1995) (24)
The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients. (1981) (24)
Measurement of specific [3H]-ouabain binding to different types of human leucocytes. (1984) (23)
The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors (2004) (23)
Platelet aggregation and chlorpromazine therapy. (1978) (23)
Decreased platelet 3H-imipramine binding sites in classical migraine. (1984) (23)
The effects of gepirone on neuroendocrine function and temperature in humans (2005) (22)
Platelet alpha-adrenoreceptors in borderline and established essential hypertension. (1983) (22)
The Multiple Causes of Vomiting: Is There a Common Mechanism? (1986) (22)
A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine. (1983) (21)
Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment. (1985) (20)
A method for the study of cation transport in vivo: effects of digoxin administration and of chronic renal failure on the disposition of an oral load of rubidium chloride. (1984) (20)
Repeated administration of subconvulsant doses of GABA antagonist drugs (2004) (20)
The Effect of Lithium on Cation Transport Measured in vivo in Patients Suffering from Bipolar Affective Illness (1989) (19)
Alteration in expression of G-protein-activated inward rectifier K+-channel subunits GIRK1 and GIRK2 in the rat brain following electroconvulsive shock (1999) (19)
Inhibition of adenyl cyclase by an exotoxin of Bacillus thuringiensis (1975) (18)
The Lilly Prize Lecture. 1996 keep on taking the tablets': pharmacological adaptation during long-term drug therapy. (2003) (18)
Malignant argentaffinoma with carcinoid syndrome and hypoglycaemia. (1971) (18)
Digoxin therapy: textbooks, theory and practice. (1976) (18)
Clinical pharmacology. Adverse drug interactions. (1981) (17)
HEADACHE AND DEPRESSION (1984) (17)
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy. (1981) (17)
Serotonin in Affective Disorders (1992) (16)
Severe "silent" mitral regurgitation after myocardial infarction: a clinical conundrum. (1992) (16)
Enhancement of specific [3H]ouabain binding and ouabain sensitive 86rubidium influx in intact human lymphocytes by a dialysable factor in human and fetal calf serum. (1987) (16)
Cation transport abnormalities in vivo in untreated essential hypertension. (1986) (16)
How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function? (1974) (15)
Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa (1976) (15)
Serotonin (5-hydroxytryptamine, 5-HT). (1988) (15)
Chronic electroconvulsive shock enhances 5-HT2 receptor-mediated head shakes but not brain c-fos induction (1996) (15)
The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse—1. Rubidium (1992) (15)
Investigation of the presynaptic effects of quinine and quinidine on the release and uptake of monoamines in rat brain tissue (1998) (15)
Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy (1979) (14)
Effect of amitriptyline on endocrine responses to intravenous L-trytophan (1990) (14)
Evidence for cholinergic vagal afferents and vagal presynaptic M1 receptors in the ferret (1994) (14)
Measurement of cation transport in vivo in healthy volunteers after the oral administration of lithium carbonate. (1989) (14)
The effects of serum, lithium, ethacrynic acid, and a low external concentration of potassium on specific [3H]-ouabain binding to human lymphocytes after incubation for 3 days. (1986) (13)
The effects of 5-HT and m-chlorophenylpiperazine (m-CPP) on the efflux of [3H]-5-HT from human perfused platelets. (1993) (13)
Evidence for increased in vivo sodium-potassium pump activity and potassium efflux in skeletal muscle of spontaneously hypertensive rats. (1990) (13)
Intravenous strontium gluconate as a kinetic marker for calcium in healthy volunteers. (1991) (12)
A non-invasive method of measuring concentrations of rubidium in rat skeletal muscle in vivo by 87Rb nuclear magnetic resonance spectroscopy: implications for the measurement of cation transport activity in vivo. (1990) (12)
Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties. (1975) (11)
Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions—I the effects of single and repeated bicuculline-induced seizures (1980) (11)
Psittacosis masquerading as rheumatic fever. (1978) (11)
How will knowledge of the human genome affect drug therapy? (1999) (10)
Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat (2005) (10)
Changes in platelet alpha 2-adrenoceptor binding post partum: possible relation to maternity blues. (1983) (10)
Neuropharmacological Adaptive Effects in the Actions of Antidepressant Drugs, ECT and Lithium (1988) (10)
Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor. (1974) (10)
Autoradiographic localization of 5-HT3 receptor ligand binding in the cat brainstem (1991) (10)
Cerebral mechanisms of mood and behaviour (1977) (9)
Some histological and metabolic properties of an isolated perfused rat brain preparation with special reference to monoamine metabolism (1976) (9)
Preclinical toxicological testing and safeguards in clinical trials (2004) (9)
The effects of a low extracellular concentration of potassium on the activity and numbers of Na+/K+ pumps in an EB-virus transformed human lymphocyte cell line. (1990) (9)
The Measurement of Transmembrane Cation Transport in vivo in Acute Manic Illness (1989) (9)
Processes regulating the functional activity of brain 5-hydroxytryptamine: results of animal experimentation and their relevance to the understanding and treatment of depression. (1978) (8)
Evidence-based medicine: challenging the orthodoxy (1998) (8)
Pharmacology of the 5-hydroxytryptamine-induced depolarization of the ferret vagus nerve in vitro. (1992) (8)
THE EFFECTS OF MONOVALENT AND DIVALENT CATIONS ON THE α‐ADRENOCEPTOR OF INTACT HUMAN PLATELETS (1982) (8)
Quinine and 4-aminopyridine inhibit the stimulatory output of dopamine in nucleus accumbens and the behavioural activity produced by morphine. (1993) (8)
An encounter with Beethoven's cleaning lady (1993) (7)
A sensitive high-temperature electrothermal atomic absorption analysis for Rb+ in erythrocytes and plasma of normal and hypertensive persons. (1985) (7)
MONOAMINE-OXIDASE INHIBITORS AND CAVIAR (1977) (7)
The Neuropharmacology of 5-HT in Anxiety (1991) (7)
The putative 5-HT1A antagonist BMY 7378 blocks 8-OH-DPAT-induced changes in local cerebral glucose utilization in the conscious rat (1992) (7)
A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole. (1989) (7)
Effects of carbamazepine on 5-hydroxytryptamine function in rodents (2005) (7)
Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition. (1974) (7)
The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia (2004) (7)
Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats (2005) (6)
The effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers. (1991) (6)
Central pharmacological control of corticosterone secretion in the intact rat. demonstration of cholinergic and serotoninergic facilitatory and α-adrenergic inhibitory mechanisms (2004) (6)
Smithkline Beecham Prize for Young Psychopharmacologists (1992) (6)
The reliability of 5-hydroxytryptamine induced platelet aggregation responses in schizophrenic patients treated with neuroleptic drugs. (1981) (6)
Proceedings: Reduction of platelet monoamine oxidase activity in iron deficiency anaemia. (1974) (6)
AS-5370 potently antagonizes 5-HT3 receptor-mediated responses on NG108-15 cells and on the rat vagus. (1992) (6)
Self-medication with mood changing drugs. (1975) (6)
The plasma digoxin concentration, red cell rubidium 86 uptake and control of ventricular rate in patients being digitalized for artrial fibrilation. (1972) (6)
5-[3H]hydroxytryptamine and [3H]lysergic acid diethylamide binding to human platelets. (1992) (5)
KO'd by R & D speak: deciphering Culyer (1994) (5)
The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse—3. Quinine (1992) (5)
Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: Interactions with deoxycytidine (2004) (5)
INCREASED SPECIFIC [H-3] OUABAIN BINDING TO LYMPHOCYTES AFTER INCUBATION WITH ACETYLSTROPHANTHIDIN FOR 3 DAYS (1985) (5)
Clinical pharmacology. Seventh edition (1993) (5)
5-HT: on the psychiatrist's couch. (1992) (5)
The effect of oral salbutamol on cation transport measured in vivo in healthy volunteers. (1990) (4)
The effect of repeated electroconvulsive shock on corticosterone responses to centrally acting pharmacological stimuli in the male rat (2004) (4)
THE EFFECT OF LITHIUM ON CATION-TRANSPORT INVIVO AND INVITRO IN HEALTHY-VOLUNTEERS (1987) (4)
The effects of rubidium, caesium and quinine on 5-ht-mediated behaviour in rat and mouse—2. Caesium (1992) (4)
Human platelet 5-hydroxytryptamine receptors: Binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration (1988) (4)
Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy. (1981) (4)
Inhibition by ouabain of spontaneous D.N.A. synthesis in acute leukaemic leucocytes in vitro. (1971) (4)
Dose-dependent inhibition of phosphoinositide metabolism in human platelets by aspirin in vitro and in vivo. (1986) (4)
Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy (1981) (4)
Adenosine 3':5'-cyclic monophosphate and adenylate cyclase in subcellular fractions of rat brain. (1972) (3)
Clinical pharmacology. Roles and responsibilities in academic research. (1991) (3)
The Metabolic Compartmentation of Brain Monoamines (1973) (3)
The effect of inhibitors of protein synthesis to inhibit brain protein synthesis and prevent the hyperactivity and hyperpyrexia in rats produced by inhibition of monoamine oxidase and the administration of L-tryptophan or 5-methoxy-NN-dimethyltryptamine. (1972) (3)
Academic pursuits in clinical pharmacology. Research emphasis. (1986) (3)
The effects on salbutamol on in vivo cation transport (1988) (3)
In vivo cation transport during short-term and long-term digoxin therapy. (1986) (3)
Differential effects of lithium on agonist-stimulated inositol polyphosphate formation in rat cerebral cortex slices: Selective actions on muscarinic cholinergic responses (1990) (3)
STIMULATION OF TRITIATED-OUABAIN BINDING TO INTACT HUMAN-LYMPHOCYTES BY NORMAL HUMAN AND FETAL CALF SERUM (1983) (3)
Comparison of the effect of buspirone and 1-(2-pyrimidinyl)-piperazine on cerebral glucose utilization in the rat. (1993) (3)
An Isolated Perfused Rat Brain Preparation—Some Histological and Metabolic Features (1974) (3)
The effect of intracerebral injection of cycloheximide on brain protein synthesis and on the hyperactivity syndrome produced by a monoamine oxidase inhibitor and tryptophan (1977) (2)
Assessment of Digoxin Action by a Pharmacodynamic Biochemical Method (1978) (2)
Contractile Activity of Cerebrospinal Fluid (CSF) from Patients with Subarachnoid Haemorrhage upon the Isolated Human Basilar Artery (1975) (2)
Pharmacological adaptive responses occurring during drug therapy and in disease (1985) (2)
Animal Hyperactivity Syndromes: Do they have any Relevance to Minimal Brain Dysfunction (1978) (2)
Lack of effect of phenytoin on functions related to Na+,K+-ATPase activity of the intact erythrocytes of epileptic patients. (1981) (2)
Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and l-dopa to rats (1978) (2)
Relevance of the enhanced 5-hydroxytryptamine behavioural responses in rats to electroconvulsive therapy [proceedings]. (1978) (2)
AMINES, ANTICONVULSANTS, AND EPILEPSY (1975) (2)
ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM (1982) (2)
The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression. (1984) (2)
COMPARISON OF THE ACTIONS OF LITHIUM, RUBIDIUM, AND CAESIUM ON RAT BRAIN 5‐HT FUNCTION: PHARMACOLOGICAL IMPLICATIONS OF ION CHANNEL FUNCTION (1992) (2)
THE EFFECTS OF LITHIUM, ETHACRYNIC-ACID, AND LOW POTASSIUM ON SPECIFIC LYMPHOCYTIC [H-3] OUABAIN BINDING (1985) (1)
A study in the guinea-pig of the pharmacokinetics and pharmacodynamics of cytosine arabinoside [proceedings]. (1978) (1)
EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY (1984) (1)
Sequential Measurement of Plasma Catecholamines and Dopamine-β-Hydroxylase (DBH) in Patients Who Have Undergone Corrective Surgery for Coarctation of the Aorta (1977) (1)
805 – THE EFFECT OF DIGOXIN THERAPY ON RED BLOOD CELL FUNCTION AND ITS RELATIONSHIP TO THE THERAPEUTIC RESPONSE (1978) (1)
THE EFFECT OF A LOW EXTERNAL POTASSIUM CONCENTRATION ON THE NA/K-ATPASE OF HUMAN-LYMPHOBLASTS (1987) (1)
Platelet 3H-Imipramine Binding in Patients with Classical Migraine (1985) (1)
Pharmacological control of corticosterone secretion in the intact rat [proceedings]. (1979) (1)
THE PHARMACOKINETICS OF INTRAVENOUS STABLE STRONTIUM IN HEALTHY-VOLUNTEERS (1989) (1)
The Disposition of Oral Rubidium Chloride in Essential Hypertension (1982) (1)
Studies on the biosynthesis of 5-Hydroxytryptamine (1966) (1)
Problems facing a regulatory authority (1981) (1)
Administration of lithium altered mRNA expression of voltage-dependent potassium channel subunits in the rat brain (2000) (1)
Studies of the clinical pharmacology of cardiac glycosides (1977) (1)
Clinical pharmacology of serotonin Proceedings of the satellite symposium on the clinical pharmacology of Serotonin, Helsinki, 26–27 July, 1975,F. Sicuteri &E. Schönbaum (Eds.) Oss. S. Karger, Basel (1976). 139 pp., DM 64.00. $24.75 (1977) (1)
Adenosine 3':5'-cyclic monophosphate as the intracellular mediator of the action of adrenocorticotrophin on the adrenal cortex. (1970) (1)
A General Perspective of Post-Marketing Surveillance (1990) (1)
Effect of age on the development and properties of brain monoamine oxidase. (1975) (1)
Clinical academic medicine: a Socratic dialogue (1997) (1)
CORRESPONDENCF SECTION Platelet a-adrenoreceptors in borderline and established essential hypertension (1983) (1)
Advances in Cyclic Nucleotide Research, Volume 3 (1975) (1)
Effect of calcium channel antagonists on electrically-evoked release of 5-HT in rat hippocampus in vivo as studied by microdialysis (1990) (1)
Measurement ofspecific (:3H)-ouabain binding todifferent types ofhumanleucocytes (1984) (1)
Monoamine metabolism in the isolated perfused rat brain. (1976) (1)
Effects of serum, lithium, ethacrynic acid, and low external concentration of potassium on specific [3H]-ouabain binding to human lymphocytes—a reply (1987) (1)
The Transfer of Tryptophan Across the Synaptosome Membrane (2008) (1)
Self-medication with mood-ch ng drugs (2005) (0)
86RUBIDIUM UPTAKE AND INTRACELLULAR SODIUM CONCENTRATIONS IN THE ERYTHROCYTES OF PATIENTS RECEIVING (2006) (0)
Today's Treatment (1981) (0)
Clinical, haemodynamic, andpharmacological effects ofwithdrawal andreintroduction ofdigoxin in patients withheart failure insinus rhythmafter long termtreatment (1989) (0)
Proceedings: Cellular biochemical pharmacology in monitoring drug therapy. (1976) (0)
Plasma adrenaline andnoradrenaline concentrations anddopamine-3-hydroxylase activity inmyocardial infarction withandwithout cardiogenic shock (1979) (0)
Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function. (1984) (0)
A role for brain protein in the process by which brain serotonin and certain other indolealkylamines produce behaviourally excitant effects in the rat. (1972) (0)
The demedicalization of prescribing (2012) (0)
Proceedings: An isolated perfused rat brain--some histological and metabolic features. (1974) (0)
BOOK REVIEWS (2009) (0)
Decreased platelet [3H]imipramine binding sites in classical migraine J. Neurol. Neurosurg. Psychiat., 47 (1984) 720–723 (1985) (0)
The effects of drugs on the processes regulating the functional activity of brain monoamines. (1979) (0)
Continuing Medical Education: 'When the Earth Screamed' (1994) (0)
The prevention by inhibitors of brain proptein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of L-tryptophan or 5-methoxy-N,N-dimethyltryptamine. (1972) (0)
EVIDENCE FOR INCREASED INVIVO NA+/H+ ANTIPORTER ACTIVITY IN SKELETAL-MUSCLE OF SPONTANEOUSLY HYPERTENSIVE RATS (1990) (0)
Enhanced Monoamine Behavioural Responses Following Repeated Electroconvulsive Shock to Rats and their Relevance to ECT (1979) (0)
Future Meetings (1978) (0)
After-dinner speech (1989) (0)
Don't knock the fruit (1991) (0)
Elements of the behavioral code By F. V. DeFeudis and P. A. F. DeFeudis, xiii + 389 pages, 93 illustrations, 38 tables, Academic Press, London, New York, San Francisco, 1977, £ 15.00, US$ 29.35 (1979) (0)
Some Processes Involved in Regulating the Function of Brain 5-Hydroxytryptamine (1975) (0)
Disorder of synaptic homeostasis in depression and its treatment (1998) (0)
HORMONAL INFLUENCES ON RECEPTOR REGULATION (1984) (0)
The effects of monovalent and divalent cations on the alpha-adrenoceptor of intact human platelets. (1982) (0)
HYPHENS (1976) (0)
The effect of repeated electroconvulsive shocks on growth hormone secretion and growth hormone responses to clonidine in the intact rat (2004) (0)
Detecting severe silent mitral regurgitation: Authors' reply (1992) (0)
ALTEREDDISTRIBUTION OFDIGOXIN INRENALFAILURE-ACAUSEOFDIGOXINTOXICITY? (1976) (0)
Evidence forthepresenceofavasoactive substance (possibly involved intheaetiology ofcerebral arterial spasm)incerebrospinal fluid frompatients with subarachnoid haemorrhage (1976) (0)
Theeffect ofnifedipine onthedisposition ofstrontium gluconate used asakinetic marker forcalcium inhealthy volunteers (1991) (0)
The demedicalization of prescribing: THE ADRIAN SALTER LECTURE 2002 (2002) (0)
DIGOXINTHERAPY: TEXTBOOKS,THEORYAND PRACTICE (1976) (0)
INVIVO EVIDENCE OF REDUCED CATION-TRANSPORT IN CHRONIC-RENAL-FAILURE (1983) (0)
Proceedings: Inhibition of adenyl cyclase by a bacterial exotoxin. (1974) (0)
β-Adrenoceptor agonists enhance the functional activity of brain 5-hydroxytryptamine: relationship to antidepressant activity (1983) (0)
Abnormal functions of pottasium channels in the platelets of patients with Alzheimer's disease (1998) (0)
THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE (1982) (0)
2653 – MONITORING DIGOXIN THERAPY: COMPARISON BETWEEN TISSUE RESPONSE AND CLINICAL EFFECTS (1978) (0)
Responses ofisolated humanbasilar arteries to 5-hydroxytryptam ine, noradrenaline, serum, platelets, anderythrocytes (1975) (0)
NORADRENERGIC TRANSMISSION IN THE PINEAL-GLAND DURING DESMETHYLIMIPRAMINE TREATMENT (1985) (0)
[H-3]-LABELED OUABAIN BINDING AND RB-86 UPTAKE IN POLYMORPHONUCLEAR AND MONONUCLEAR LEUKOCYTES (1983) (0)
Effects of some Adrenocorticotrophin Analogues on Protein Synthesis in Brain (2005) (0)
The In VIVO Disposition of Lithium in Patients with Untreated Essential Hypertension (1988) (0)
Effects of chronic lithium, amitriptyline, and electroconvulsive shock, on calcium channel binding in a rat brain homogenate (2006) (0)
Pharmacological control ofcorticosterone secretion intheintact rat (1979) (0)
CHANGESINCARDIAC GLYCOSIDERECEPTORSITES, 86RUBIDIUM UPTAKEAND INTRACELLULAR SODIUMCONCENTRATIONS INTHE ERYTHROCYTES OFPATIENTS RECEIVING DIGOXINDURINGTHEEARLYPHASES OFTREATMENTOFCARDIACFAILUREIN REGULARRHYTHMAND OFATRIALFIBRILLATION (1979) (0)
PLATELET (H-3)-LSD BINDING IN PATIENTS ON CHRONIC PHENOTHIAZINE AND THIOXANTHENE THERAPY (1984) (0)